Catalysts for $IGC
651 tracked
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 31, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Oct 30, 2024
recall
C & A Naturistics recall (Cls II)
IGC Pharma, Inc.
→
Sep 19, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Sep 19, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Sep 19, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Apr 9, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Apr 3, 2024
approval
PERCOCET (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Apr 3, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Apr 3, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Apr 3, 2024
approval
PERCOCET (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
BUPRENORPHINE HYDROCHLORIDE
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Mar 20, 2024
approval
BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approval
IGC Pharma, Inc.
→
Mar 19, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Mar 18, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Mar 18, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Mar 15, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Mar 14, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→
Mar 13, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Mar 13, 2024
approval
OXYCODONE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
acetaminophen ER
→
Mar 11, 2024
approval
HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN) — FDA approval
IGC Pharma, Inc.
→